Skip to main content
An official website of the United States government

2017 Technology Showcase

June 7, 2017 | 12:00 PM – 6:00 PM

Frederick National Laboratory Advanced Technology Research Facility Frederick, MD

Add to Outlook Calendar

Event Overview

  • Free, half-day event
  • Features NCI and FNL researchers who will highlight technologies available for licensing and collaboration
  • Learn about technologies primed for commercialization and/or collaboration; great opportunity for biotech stakeholders and companies of all sizes including start-ups.
  • Showcases how to partner with the NCI and the FNL including the company perspective.
  • Poster Session highlighting additional NIH technologies available for licensing and collaborative development - presented by the NCI Technology Transfer Ambassadors Program.
  • In-person networking opportunities.
  • The Technology Showcase will conclude with an independently sponsored networking event nearby without involving any resources of the Department of Health and Human Services.
Frederick National Laboratory

The Advanced Technology Research Facility at the Frederick National Laboratory

Detailed Event Schedule

Event Agenda
Program Schedule Topics and Events
12:30 - 1:00 p.m.


1:00 - 1:15 p.m.

Welcome and Introduction

Moderator: Andrew Quong, Ph.D., Director, Strategic Scientific Initiatives & Partnerships, FNLCR

  • David Heimbrook, Ph.D., Laboratory Director, FNLCR
  • Jan Gardner, County Executive, Frederick County MD
  • Randy McClement, Mayor, the City of Frederick
1:15 - 2:00 p.m.

Stakeholder Presentations

Moderator: Ron Kaese, Director, Federal Programs, Maryland Technology Development Corporation (TEDCO)

  • Brad Fackler, M.B.A., Senior Director of BioHealth and Life Sciences, Maryland Department of Commerce
  • Helen Propheter, Director, Frederick County Office of Economic Development
  • Richard Griffin, AICP, CEcD, Director, The City of Frederick Office of Economic Development
  • James Pannucci, Ph.D., Director, Partnership Development Office, FNLCR
  • Martin Rosendale, Director of Biosciences, Technology Council of Maryland
  • Kathie Callahan Brady, M.B.A., CEO, Frederick Innovative Technology Center, Inc. (FITCI)
  • Karen Maurey, M.S., Director, NCI Technology Transfer Center (TTC)
  • Matt Portnoy, Ph.D., Program Manager, NIH Small Business Innovation Research (SBIR)
  • Barry Datlof, M.B.A., Director, Medical Technology Transfer, U.S. Army Medical Research and Materiel Command, Fort Detrick
2:00 - 3:15 p.m.

Technology Presentations, Session 1

Moderator: Michael Salgaller, Ph.D., Invention Development and Marketing Unit Lead, NCI TTC

  • “DICOM Tool, a Quantitation Java Application for the Argus/BioPET Preclinical PET/CT Scanner” - E-138-2015
    Steven Adler, Ph.D., FNLCR, Clinical Monitoring Research Program –
  • “Developing Vaccines Against Human Polyomaviruses” - E-168-2001
    Chris Buck, Ph.D., Laboratory of Cellular Oncology, NCI, Center for Cancer Research (CCR) –
  • “Ability to Produce Custom Antibodies” - E-079-2008
    Dimiter Dimitrov, Ph.D., Cancer and Inflammation Program, NCI, CCR –
  • “New Insect Cell Technologies for High-quality and High-yield Production of Therapeutically Relevant Proteins” - E-009-2008, E-287-2012, E-146-2017
    Dominic Esposito, Ph.D., FNLCR RAS Initiative
  • “Enhancing Cancer Immunotherapy by Epigenetically Reprogramming Tumor-Reactive CD8+ T Cells with the Polycomb-like Protein Phf19” - E-107-2017
    Luca Gattinoni, M.D. (Principal Investigator) and Yun Ji, Ph.D. (Staff Scientist), Experimental Transplantation and Immunology Branch, NCI CCR
3:15 - 3:30 p.m.


3:30 - 4:45 p.m.

Technology Presentations, Session 2

Moderator: Kathie Brady, FITCI

  • “Biomarkers to Better Predict Cancer Survival" - E-025-2009
    Stephen Hewitt, M.D., Ph.D., Laboratory of Experimental Pathology, NCI, CCR
  • “Novel Immuno-Oncology Therapy Targeting Glypican-2 in Neuroblastoma” - E-211-2016
    Mitchell Ho, Ph.D., Laboratory of Molecular Biology, NCI, CCR
  • “HMGN1” - E-185-2008
    Joost Oppenheim, M.D., Cancer and Inflammation Program, NCI, CCR
  • “CD276 Antibody” - E-250-2014
    Brad St. Croix, Ph.D., Mouse Cancer Genetics Program, NCI, CCR
  • “Stable Isotope Tracer Method for Evaluation of Nanomedicine Pharmacokinetics and Bioequivalence” - E-163-2016
    Stephan Stern, Ph.D., FNLCR, Nanotechnology Characterization Laboratory
4:45 - 5:00 p.m.

Success Story

Darryl Sampey, Ph.D., President & CEO, BioFactura (Frederick, MD)

5:00 - 6:00 p.m.

Networking and Poster Session

5:00 - 7:00 p.m.

Frederick BioBeers Meet Up

Independently sponsored networking event nearby without involving any resources of the Department of Health and Human Services.